AKR1C1 and non-small cell lung carcinoma: AKR1C1 belongs to the human aldo-keto reductase (AKR) family, whose aberrant expression has been shown to be induced during development of resistance to a variety of chemotherapeutic drugs with carcinogenesis of NSCLC, breast and ovarian cancers48,49.